Specifically, K19 expression, serum CYFRA 21‐1 (≥ 2.7 ng/mL), tumor size (≥5 cm), the presence of multiple tumors, poor tumor differentiation, and microvascular invasion were associated with lower RFS rates according to log‐rank tests (Table S3). Here, KRT19 is linked to neoplasm.